CLAHRC North Thames PhD Marissa Mes enjoyed success at the prestigious Annual Scientific Meeting (ASM) of the Asthma UK Centre for Applied Research (AUK CAR).
Marissa won best poster presentation when she showcased her work to delegates during the conference (below) – her research focus is assessing whether pharmacists are a suitable delivery channel for an intervention aimed at asthma patients to improve their adherence to preventer inhalers.
Our congratulations to Marissa on her prize.
Marissa’s fellow CLAHRC PhD Caroline Katzer, who is developing and evaluating an intervention to improve adherence to inhaled corticosteroids (ICS) in adult asthma patients also showcased her work at the conference via both a poster and an oral presentation, which generated a lot of discussion, and was among those complimented on the quality of her presentations.
Both PhDs are funded by the CLAHRC and affiliated to AUKCAR.
CLAHRC behaviour change researchers and PhDs Caroline Katzer and Marissa Mes were a big hit at the recent in ESPACOMP conference in Budapest Hungary. Caroline and Marissa presented to an audience of clinicians and allied health professionals interested in adherence
ESPACOMP (European Society for Patient Adherence, COMpliance and Persistence) promotes science concerned with the assessment of what patients do with medicines they have been prescribed – and the implications when they adhere, or don’t adhere to them. Their 2017 conference brought together behaviour change practitioners and researchers from across the world and both Marissa and Caroline’s presentation generated much interest and a host of questions from the audience.
Media coverage of the use of statins to prevent cardiovascular disease, of Tamiflu to treat flu and of the HPV vaccine to prevent cervical cancer have opened up public debate about medical and scientific claims.
The report and associated resources will help health professionals to improve the use of scientific evidence to judge the potential benefits and harms of medicines. This will lead to better, more informed conversations between professional and patient about the benefits and risks of prescribing (or not prescribing) a particular medicine.